GENE ONLINE|News &
Opinion
Blog

2026-02-04|

CEA Industries Requests Termination of Undisclosed Side Agreement Between 10X Capital and YZi Labs

by GOAI
Share To

CEA Industries has formally requested that 10X Capital and YZi Labs terminate a private side agreement between the two entities. The company raised concerns about the undisclosed nature of this arrangement, which it claims could potentially impact its business interests and shareholder value. The request follows an internal review conducted by CEA Industries regarding agreements involving its partners.

According to sources familiar with the matter, CEA Industries alleges that the side agreement between 10X Capital and YZi Labs was not disclosed during prior negotiations or partnerships. The company has emphasized the importance of transparency in all dealings and has urged both parties to address the issue promptly. Further details on the contents or implications of the agreement have not been disclosed at this time.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 4, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Lilly Acquires Orna Therapeutics in $2.4B to Scale In Vivo CAR-T Cell Therapies
2026-02-10
CCHH Receives Nasdaq Notice for Falling Below $1.00 Minimum Bid Price
2026-02-10
South African Patent Office Grants Manganese X Energy Corp. Patent for High-Purity Manganese Processing Technology
2026-02-10
Study Explores Impact of Symptoms on Health-Related Quality of Life in Older Swedish Men
2026-02-10
Study Finds Gaps in Support Systems for Parents Using At-Home Medical Devices for Children with Complex Needs
2026-02-10
Radiopharmaceutical Industry Faces Talent Shortage Amid Rapid Expansion
2026-02-10
FTI Consulting Expands Middle East Healthcare Advisory with Two Senior Hires
2026-02-09
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
Scroll to Top